PH23716A - A pharmaceutical composition for the treatment of high blood pressure - Google Patents

A pharmaceutical composition for the treatment of high blood pressure

Info

Publication number
PH23716A
PH23716A PH34228A PH34228A PH23716A PH 23716 A PH23716 A PH 23716A PH 34228 A PH34228 A PH 34228A PH 34228 A PH34228 A PH 34228A PH 23716 A PH23716 A PH 23716A
Authority
PH
Philippines
Prior art keywords
treatment
pharmaceutical composition
blood pressure
high blood
converting enzyme
Prior art date
Application number
PH34228A
Other languages
English (en)
Inventor
Reinhard Becker
Rolf Geiger
Rainer Henning
Volker Teetz
Hansjoerg Urbach
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6280420&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH23716(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PH23716A publication Critical patent/PH23716A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Toys (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH34228A 1985-09-09 1986-09-08 A pharmaceutical composition for the treatment of high blood pressure PH23716A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853532036 DE3532036A1 (de) 1985-09-09 1985-09-09 Pharmazeutische zubereitung zur behandlung des bluthochdrucks

Publications (1)

Publication Number Publication Date
PH23716A true PH23716A (en) 1989-09-27

Family

ID=6280420

Family Applications (1)

Application Number Title Priority Date Filing Date
PH34228A PH23716A (en) 1985-09-09 1986-09-08 A pharmaceutical composition for the treatment of high blood pressure

Country Status (19)

Country Link
EP (1) EP0215357B1 (no)
JP (1) JPH089549B2 (no)
KR (1) KR940010032B1 (no)
AT (1) ATE75610T1 (no)
AU (1) AU597270B2 (no)
CA (1) CA1340722C (no)
DE (2) DE3532036A1 (no)
DK (1) DK166755B1 (no)
ES (1) ES2001940A6 (no)
FI (1) FI863594A (no)
GR (1) GR862285B (no)
HU (1) HU200685B (no)
IE (1) IE59308B1 (no)
IL (1) IL79965A (no)
NO (1) NO863583L (no)
NZ (1) NZ217489A (no)
PH (1) PH23716A (no)
PT (1) PT83322B (no)
ZA (1) ZA866810B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337400C (en) * 1987-06-08 1995-10-24 Norma G. Delaney Inhibitors of neutral endopeptidase
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
AU2001255730A1 (en) * 2000-04-26 2001-11-07 First Horizon Pharmaceutical Corporation Methods and compositions for the treatment of cardiac indications
US20080234353A1 (en) 2004-03-24 2008-09-25 Reynir Eyjolfsson Formulations of Ramipril
PL3173075T3 (pl) 2015-11-27 2019-04-30 Accupharma Spolka Z Ograniczona Odpowiedzialnoscia Farmaceutyczny preparat złożony inhibitora ACE i diuretyku pętlowego

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283407A (en) * 1977-09-28 1981-08-11 Science Union Et Cie Thiopropionamides, and the pharmaceutical compositions
CA1120400A (en) * 1977-12-27 1982-03-23 Zola P. Horovitz Method of treating hypertension and medicaments therefor
US4217347A (en) * 1977-12-27 1980-08-12 E. R. Squibb & Sons, Inc. Method of treating hypertension and medicaments therefor
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
FR2419728A1 (fr) * 1979-01-05 1979-10-12 Science Union & Cie Nouvelles compositions pharmaceutiques a action hypotensive et procede pour les preparer
US4482725A (en) * 1980-04-03 1984-11-13 E. R. Squibb & Sons, Inc. S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
JPS56145220A (en) * 1980-04-10 1981-11-11 Dainippon Pharmaceut Co Ltd Antihypertensive agent containing prolylamino acid derivative and diuretic agent as main constituent

Also Published As

Publication number Publication date
DK166755B1 (da) 1993-07-12
CA1340722C (en) 1999-09-07
FI863594A (fi) 1987-03-10
NZ217489A (en) 1990-07-26
DE3685177T (no) 1992-06-11
EP0215357B1 (de) 1992-05-06
IE862392L (en) 1987-03-09
GR862285B (en) 1987-01-12
PT83322A (pt) 1986-10-01
AU597270B2 (en) 1990-05-31
DE3685177D1 (de) 1992-06-11
IL79965A (en) 1990-08-31
HU200685B (en) 1990-08-28
DK427886D0 (da) 1986-09-08
AU6243186A (en) 1987-03-12
EP0215357A2 (de) 1987-03-25
KR940010032B1 (ko) 1994-10-21
ATE75610T1 (de) 1992-05-15
IE59308B1 (en) 1994-02-09
DK427886A (da) 1987-03-10
NO863583L (no) 1987-03-10
KR870002844A (ko) 1987-04-13
ES2001940A6 (es) 1988-07-01
ZA866810B (en) 1987-04-29
HUT41640A (en) 1987-05-28
DE3532036A1 (de) 1987-03-26
JPS6261928A (ja) 1987-03-18
JPH089549B2 (ja) 1996-01-31
PT83322B (pt) 1989-05-12
IL79965A0 (en) 1986-12-31
FI863594A0 (fi) 1986-09-05
EP0215357A3 (en) 1989-07-26
NO863583D0 (no) 1986-09-08

Similar Documents

Publication Publication Date Title
GR890100838A (el) Νέα ?εραπευτικώς δραστική ένωσις και μέ?οδος για την παραγωγή της.
ZA896468B (en) Lyophilization of red blood cells
AU6739387A (en) Method and device for determining the colour, particularly of a dental prosthesis
AU5804686A (en) Regulation of degradation processes in bone
AU1924588A (en) Non-bunching cinch ring for self-applied blood pressure cuff
ZA866810B (en) A pharmaceutical composition for the treatment of high blood pressure
MY102991A (en) Medicaments for treating hypertension.
AU4090589A (en) The use of plasminogen activator inhibitor (pai-2) for immunosuppression
IT8622122A0 (it) Adesivo per protesi dentarie osimilari e procedimento per la sua fabbricazione.
AU7037987A (en) Oxygen generating herbicides synergized with detoxifying enzyme inhibitor
AU7071487A (en) Chlorpheniramine therapy
AR243513A1 (es) Procedimiento para la preparacion de 1-fenilquinazolin-1h,3h-2,4-dionas y 1-fenilpirido¡2,3-d¿pirimidin-1h,3h-2,4-dionas
AU7186487A (en) Use of D. bardawil as a source of vitamin A and a yolk-color enhancing agent
AU7999687A (en) Active compounds for preventing tumor metastases
EP0215395A3 (en) Pharmaceutical composition for retarding and reducing cachexia
AU7647187A (en) Tourniquet for parts of the body
IE872614L (en) Pharmaceutical composition for the treatment of high blood¹pressure
AU613510B2 (en) Use of zofenopril for the treatment of rheumatoid arthritis
GB2197199B (en) Medicament for treatment of pregnancy-induced hypertension.
EP0351017A3 (en) Pharmaceutical composition useful for the treatment of cardiovascular diseases
AU7125887A (en) Peptides affecting blood pressure regulation
GB8709444D0 (en) Reduction of high blood pressure
JO1498B1 (en) A new treatment for joints and nerves
AR242544A1 (es) Procedimiento para la preparacion de una alumina activa de alta pureza y la alumina asi obtenida.
CS719388A1 (en) Derivatives of thioallophanic acid